Publisher's Synopsis
These Programme for Vaccine Development proceedings explore approaches to producing vaccines in the developing countries: the use of live agents; the use of anti-idiotype antibodies; the introduction of DNA or cDNA coding for a protective antigen of the disease agent into a mammalian cell line, lower eukaryote, or bacterium; and the synthesis of oligopeptides corresponding to an epitope or a protective antigen of the disease agent.